MEA AI in Bioinformatics Market - Industry Trends and Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143100
- Pages: 225
-
Format:
Short Description
Middle East and Africa AI in Bioinformatics Market, By Offering (Software, Services, and Others), Type (Machine Learning, Deep Learning, and Others), Products and Services (Knowledge Management Tools, Bioinformatics Platforms and Bioinformatic Services), Application (Genomics, Microarrays, System Biology, Text Mining, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, DNA Sequencing, Metabolomics, and Others), Sector (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology, and Other Sectors), Industry Trends and Forecast to 2029
Market Definition
Bioinformatics is a sub-discipline that has to do with the analysis of sequences of biological molecules. It usually refers to genes, DNA, RNA, or protein, and is particularly useful in comparing genes and other sequences in proteins and other sequences within an organism or between organisms, looking at the evolutionary relationships between organisms, and using the patterns that exist across DNA and protein sequences to figure out what their function is.
Bioinformatics combines computer programming, big data, and Molecular Biology, which enables scientists to understand and identify patterns in biological data. It is particularly useful in studying genomes and DNA sequencing, as it allows scientists to organize large amounts of data.
From genetics to toxicology to mycology and radiobiology, there are scores of branches of biology to specialize in. And out of the many, bioinformatics is one of the intriguing fields which enables you to identify, evaluate, store, and retrieve biological information. Being an interdisciplinary field of study, it incorporates various applications of computer science, statistics, and biology to develop software applications for understanding biological data like DNA sequencing, protein analysis, evolutionary genetics, and others.
In the coming future, important decisions related to bioinformatics on drug discovery will be made by individuals who not only understand biology but can also use the bioinformatics tools and the knowledge they release to develop hypotheses and identify the quality target.
Market Segmentation
The AI in bioinformatics market is categorized into five notable segments such as offering, type, products and services, application, and other sectors.
On the basis of offering, the Middle East and Africa AI in bioinformatics market is segmented into software, services, and others
On the basis of type, the Middle East and Africa AI in bioinformatics market is segmented into machine learning, deep learning, and others
On the basis of products and services, the Middle East and Africa AI in bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bioinformatics services
On the basis of application, the Middle East and Africa AI in bioinformatics market is segmented into genomics, microarrays, system biology, text mining, chemoinformatics & drug design, proteomics, transcriptomics, DNA sequencing, metabolomics, and others
On the basis of sector, the Middle East and Africa AI in bioinformatics market is segmented into medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, and other sectors
Market Players
Some of the major players operating in the Middle East and Africa AI in bioinformatics market are:
SOPHiA GENETICS
Biomax Informatics Inc.
QIAGEN
NeoGenomics Laboratories
Eurofins Scientific
Illumina, Inc.
Thermo Fisher Scientific, Inc.
Dassault Systmes
SomaLogic Operating Co., Inc.
TABLE OF CONTENTS
1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.3 OVERVIEW OF MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET 27
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 30
2 MARKET SEGMENTATION 32
2.1 MARKETS COVERED 32
2.2 GEOGRAPHICAL SCOPE 33
2.3 YEARS CONSIDERED FOR THE STUDY 34
2.4 CURRENCY AND PRICING 34
2.5 DBMR TRIPOD DATA VALIDATION MODEL 35
2.6 MULTIVARIATE MODELLING 38
2.7 OFFERING LIFELINE CURVE 38
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 39
2.9 DBMR MARKET POSITION GRID 40
2.10 MARKET SECTOR COVERAGE GRID 41
2.11 VENDOR SHARE ANALYSIS 42
2.12 SECONDARY SOURCES 43
2.13 ASSUMPTIONS 43
3 EXECUTIVE SUMMARY 44
4 PREMIUM INSIGHTS 47
4.1 PESTEL ANALYSIS 48
4.2 PORTERS FIVE FORCES 49
5 MARKET OVERVIEW 50
5.1 DRIVERS 52
5.1.1 REDUCTION IN THE GENETIC SEQUENCING COST 52
5.1.2 GROWING DEMAND FOR BIOINFORMATICS 53
5.1.3 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS 53
5.2 RESTRAINTS 54
5.2.1 HIGH COST OF INSTRUMENTATION 54
5.2.2 CYBERSECURITY CONCERNS IN BIOINFORMATICS 54
5.3 OPPORTUNITIES 55
5.3.1 RISE IN HEALTHCARE EXPENDITURE 55
5.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS 55
5.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY 56
5.4 CHALLENGES 56
5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM AI-BASED BIOINFORMATICS TECHNOLOGY 56
5.4.2 CHALLENGES OF IMPLEMENTING BIOINFORMATIC TECHNOLOGY IN THE CLINICAL LAB 57
6 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY OFFERING 58
6.1 OVERVIEW 59
6.2 SERVICES 62
6.3 SOFTWARE 62
6.4 OTHERS 63
7 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY TYPE 65
7.1 OVERVIEW 66
7.2 MACHINE LEARNING 69
7.3 DEEP LEARNING 69
7.4 OTHERS 70
8 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES 72
8.1 OVERVIEW 73
8.2 BIOINFORMATICS SERVICES 76
8.2.1 DATA ANALYSIS 77
8.2.2 SEQUENCING SERVICES 77
8.2.3 DATABASE MANAGEMENT 77
8.2.4 OTHERS 77
8.3 BIOINFORMATICS PLATFORMS 77
8.3.1 SEQUENCE ANALYSIS PLATFORMS 78
8.3.2 SEQUENCE ALIGNMENT PLATFORMS 78
8.3.3 STRUCTURAL ANALYSIS PLATFORMS 79
8.3.4 SEQUENCE MANIPULATION PLATFORMS 79
8.3.5 OTHERS 79
8.4 KNOWLEDGE MANAGEMENT TOOLS 79
8.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS 80
8.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS 80
9 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY APPLICATION 81
9.1 OVERVIEW 82
9.2 GENOMICS 85
9.3 CHEMOINFORMATICS & DRUG DESIGN 85
9.4 PROTEOMICS 86
9.5 DNA SEQUENCING 87
9.6 SYSTEM BIOLOGY 88
9.7 TRANSCRIPTOMICS 89
9.8 TEXT MINING 90
9.9 MICROARRAYS 91
9.10 METABOLOMICS 92
9.11 OTHERS 93
10 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY SECTOR 94
10.1 OVERVIEW 95
10.2 MEDICAL BIOTECHNOLOGY 98
10.3 ANIMAL BIOTECHNOLOGY 98
10.4 PLANT BIOTECHNOLOGY 99
10.5 ENVIRONMENTAL BIOTECHNOLOGY 100
10.6 FORENSIC BIOTECHNOLOGY 101
10.7 OTHERS 102
11 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY REGION 103
11.1 MIDDLE EAST AND AFRICA 104
11.1.1 SOUTH AFRICA 111
11.1.2 ISRAEL 114
11.1.3 SAUDI ARABIA 117
11.1.4 U.A.E 120
11.1.5 EGYPT 123
11.1.6 REST OF MIDDLE EAST AND AFRICA 126
12 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: COMPANY LANDSCAPE 127
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 127
13 SWOT ANALYSIS 128
14 COMPANY PROFILES 129
14.1 ILLUMINA, INC. 129
14.1.1 COMPANY SNAPSHOT 129
14.1.2 REVENUE ANALYSIS 129
14.1.3 COMPANY SHARE ANALYSIS 130
14.1.4 PRODUCT PORTFOLIO 130
14.1.5 RECENT DEVELOPMENTS 130
14.2 DASSAULT SYSTEMES 131
14.2.1 COMPANY SNAPSHOT 131
14.2.2 REVENUE ANALYSIS 131
14.2.3 COMPANY SHARE ANALYSIS 132
14.2.4 PRODUCT PORTFOLIO 132
14.2.5 RECENT DEVELOPMENT 132
14.3 EUROFINS SCIENTIFIC 133
14.3.1 COMPANY SNAPSHOT 133
14.3.2 REVENUE ANALYSIS 133
14.3.3 COMPANY SHARE ANALYSIS 134
14.3.4 PRODUCT PORTFOLIO 134
14.3.5 RECENT DEVELOPMENTS 134
14.4 THERMO FISHER SCIENTIFIC INC. 135
14.4.1 COMPANY SNAPSHOT 135
14.4.2 REVENUE ANALYSIS 135
14.4.3 COMPANY SHARE ANALYSIS 136
14.4.4 PRODUCT PORTFOLIO 136
14.4.5 RECENT DEVELOPMENTS 136
14.5 QIAGEN 137
14.5.1 COMPANY SNAPSHOT 137
14.5.2 COMPANY SHARE ANALYSIS 137
14.5.3 PRODUCT PORTFOLIO 137
14.5.4 RECENT DEVELOPMENTS 137
14.6 SOPHIA GENETICS 138
14.6.1 COMPANY SNAPSHOT 138
14.6.2 PRODUCT PORTFOLIO 138
14.6.3 RECENT DEVELOPMENT 138
14.7 ARDIGEN 139
14.7.1 COMPANY SNAPSHOT 139
14.7.2 PRODUCT PORTFOLIO 139
14.7.3 RECENT DEVELOPMENTS 139
14.8 BIOMAX INFORMATICS AG 140
14.8.1 COMPANY SNAPSHOT 140
14.8.2 PRODUCT PORTFOLIO 140
14.8.3 RECENT DEVELOPMENT 140
14.9 CELBRIDGESCIENCE. 141
14.9.1 COMPANY SNAPSHOT 141
14.9.2 PRODUCT PORTFOLIO 141
14.9.3 RECENT DEVELOPMENTS 141
14.10 DNASTAR 142
14.10.1 COMPANY SNAPSHOT 142
14.10.2 PRODUCT PORTFOLIO 142
14.10.3 RECENT DEVELOPMENTS 142
14.11 ELUCIDATA 143
14.11.1 COMPANY SNAPSHOT 143
14.11.2 PRODUCT PORTFOLIO 143
14.11.3 RECENT DEVELOPMENTS 143
14.12 FIOS GENOMICS 144
14.12.1 COMPANY SNAPSHOT 144
14.12.2 PRODUCT PORTFOLIO 144
14.12.3 RECENT DEVELOPMENTS 144
14.13 INDX. AI. 145
14.13.1 COMPANY SNAPSHOT 145
14.13.2 PRODUCT PORTFOLIO 145
14.13.3 RECENT DEVELOPMENTS 145
14.14 INSILICO MEDICINE 146
14.14.1 COMPANY SNAPSHOT 146
14.14.2 PRODUCT PORTFOLIO 146
14.14.3 RECENT DEVELOPMENTS 146
14.15 JADBIO & GNOSIS DATA ANALYSIS 148
14.15.1 COMPANY SNAPSHOT 148
14.15.2 PRODUCT PORTFOLIO 148
14.15.3 RECENT DEVELOPMENTS 148
14.16 NEOGENOMICS LABORATORIES 150
14.16.1 COMPANY SNAPSHOT 150
14.16.2 REVENUE ANALYSIS 150
14.16.3 PRODUCT PORTFOLIO 151
14.16.4 RECENT DEVELOPMENTS 151
14.17 PAIGE AI, INC. 152
14.17.1 COMPANY SNAPSHOT 152
14.17.2 PRODUCT PORTFOLIO 152
14.17.3 RECENT DEVELOPMENTS 152
14.18 SOMALOGIC OPERATING CO., INC. 153
14.18.1 COMPANY SNAPSHOT 153
14.18.2 PRODUCT PORTFOLIO 153
14.18.3 RECENT DEVELOPMENTS 153
14.19 SOURCE BIOSCIENCE. 154
14.19.1 COMPANY SNAPSHOT 154
14.19.2 PRODUCT PORTFOLIO 154
14.19.3 RECENT DEVELOPMENTS 154
14.20 STRAND LIFE SCIENCES 155
14.20.1 COMPANY SNAPSHOT 155
14.20.2 PRODUCT PORTFOLIO 155
14.20.3 RECENT DEVELOPMENTS 155
15 QUESTIONNAIRE 156
16 RELATED REPORTS 159
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
